Out-of-proportion pulmonary hypertension and heart failure with preserved ejection fraction

Respiration

Volumn 85, Issue 6, 2013, Pages 471-477

  Adir, Yochai ^a   Humbert, Marc ^b,c,d   Sitbon, Olivier ^b,c,d   Wolf, Rafael ^a   Lador, Frédéric ^b,c,d   Jaïs, Xavier ^b,c,d   Simonneau, Gérald ^b,c,d   Amir, Offer ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c BICÊTRE HOSPITAL   (France)

^d CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

Heart failure with preserved ejection fraction; Idiopathic pulmonary arterial hypertension; Metabolic syndrome; Pulmonary hypertension; Vascular stiffness

Indexed keywords

AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART RIGHT ATRIUM PRESSURE; HUMAN; HYPERLIPIDEMIA; LUNG ARTERY PRESSURE; MALE; MEDICAL RECORD REVIEW; METABOLIC SYNDROME X; POSTMENOPAUSE; PRESSURE GRADIENT; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HYPERTENSION; OBESITY; PULSE PRESSURE; RETROSPECTIVE STUDY;

AGED; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE VOLUME;

NITRIC OXIDE;

EID: 84878481543     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000339595     Document Type: Article

References (39)

1. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R: Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 30; 54:S43-S54.
2. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J: ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc. ; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009; 53: 1573-1619.
3. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G: Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34: 1219-1263.
4. Galiè N, Hoeper MM, Humbert M, et al: Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30: 2493-2537.
5. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251-259.
6. Hogg K, Swedberg K, McMurray J: Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 2004; 43: 317-327.
7. Gabby E, Yeow W, Playford D: Pulmonary arterial hypertension is an uncommon cause of pulmonary hypertension in an unselected population: the Armadale Echocardiography Study. Am J Respir Crit Care Med 2007; 175:A713.
8. Grundy SM, Brewer HB Jr, Cleeman JI, et al: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/ American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438.
9. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
10. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
11. Dwyer EM, Asif M, Ippolito T, Gillespie M: Role of hypertension, diabetes, obesity, and race in the development of symptomatic myocardial dysfunction in a predominantly minority population with normal coronary arteries. Am Heart J 2000; 139: 297-304.
12. De las Fuentes L, Brown AL, Mathews SJ, Waggoner AD, Soto PF, Gropler RJ, Dávila-Román VG: Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. Eur Heart J 2007; 28: 553-559.
13. Zamanian RT, Hansmann G, Snook S, Lilienfeld D, Rappaport KM, Reaven GM, Rabinovitch M and Doyle RL: Insulin resistance in pulmonary arterial hypertension. Eur Respir J 2009; 33: 318-324.
14. Robbins IM, Newman JH, Johnson RF, Hemnes AR, Fremont RD, Piana RN, Zhao DX, Byrne DW: Association of the metabolic syndrome with pulmonary venous hypertension. Chest 2009; 136: 31-36.
15. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Simonneau G: Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006; 173: 1023-1030.
16. Hurdman J, Condliffe R, Elliot CA, Davies C, Hill C, Wild JM, Capener D, Sephton P, Hamilton N, Armstrong IJ, Billings C, Lawrie A, Sabroe I, Akil M, O'Toole L, Kiely DG: ASPIRE Registry: assessing the spectrum of pulmonary hypertension identified at a referral centre. Eur Respir J 2012; 39: 945-955.
17. Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbély A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL: How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28: 2539-2550.
18. Montani D, O'Callaghan S, Jaïs X, Savale L, Natali D, Redzepi A, Hoette S, Parent F, Sitbon O, Simonneau G, Humbert M: Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre. Eur RespIR Rev 2009; 18: 272-290.
19. Sitbon O, Humbert M, Jaïs X, Ioos V, Hamid AM, Provencher S, Garcia G, Parent F, Hervé P, Simonneau G: Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005; 111: 3105-3111.
20. McMurray JJ, Carson PE, Komajda M, et al: Heart failure with preserved ejection fraction: clinical characteristics of 4, 133 patients enrolled in the I-PRESERVE trial. Eur J Heart Fail 2008; 10: 149-152.
21. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251-259.
22. Hogg K, Swedberg K, McMurray J: Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 2004; 43: 317-327.
23. Wai-Kwok YG, Frenneaux M, Sanderson JE: Heart failure with a normal ejection fraction: new developments. Heart 2009; 95; 1549-1552.
24. Maeder MT, Kaye DM: Heart failure with normal left ventricular ejection fraction. J Am Coll Cardiol 2009; 53: 905-918.
25. Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, Giles S, Feldkircher K, Miller DP, McGoon MD: Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry. Chest 2010; 137; 376-387.
26. Thenappan T, Shah SJ, Gomberg-Maitland M, Collander B, Vallakati A, Shroff P, Rich S: Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction. Circ Heart Fail 2011; 4: 257-265.
27. Berger G, Hardak E, Obaid W, Shaham B, Carasso S, Kerner A, Yigla M, Azzam ZS: Characterization of pulmonary venous hypertension patients with reactive pulmonary hypertension as compared to proportional pulmonary hypertension. Respiration 2012; 83: 494-498.
28. Rifaie O, El-Damanhory H, Amr M, Nammas W: Prevalence and predictors of pulmonary hypertension in elderly patients with isolated diastolic heart failure. Kardiol Pol 2010;68: 655-661.
29. Kawaguchi M, Hay I, Fetics B, et al: Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003; 107: 714-720.
30. Saito M, Okayama H, Nishimura K, et al: Possible link between large artery stiffness and coronary flow velocity reserve. Heart 2008; 94:e20.
31. Leung CC, Moondra V, Catherwood E, Andrus BW: Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction. Am J Cardiol 2010; 106: 284-286.
32. Hosoda Y, Kawano K, Yamasawa F, Ishii T, Shibata T, Inayama S: Age-dependent changes of collagen and elastin content in human aorta and pulmonary artery. Angiology 1984; 35: 615-621.
33. Plank L, James J, Wagenvoort CA: Caliber and elastin content of the pulmonary trunk. Arch Pathol Lab Med 1980; 104: 238-241.
34. Harris P, Heath D, Apostolopoulos A: Extensibility of the human pulmonary trunk. Br Heart J 1965; 27: 651-659.
35. Mackay EH, Banks J, Sykes B, Lee G: Structural basis for the changing physical properties of human pulmonary vessels with age. Thorax 1978; 33: 335-344.
36. Lam CSP, Borlaug BA, Kane GC, Enders FT, Rodeheffer RJ, Redfield MM: Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation 2009; 119: 2663-2670.
37. Sibbald WJ, Paterson NA, Holliday RL, Anderson RA, Lobb TR, Duff JH: Pulmonary hypertension in sepsis: measurement by the pulmonary arterial diastolic-pulmonary wedge pressure gradient and the influence of passive and active factors. Chest 1978; 73: 583-591.
38. Cozzi PJ, Hall JB, Schmidt GA: Pulmonary artery diastolic-occlusion pressure gradient is increased in acute pulmonary embolism. Crit Care Med 1995; 23: 1481-1484.
39. Kim NHS, Fesler P, Channick RN, Knowlton KU, Ben-Yehuda O, Lee SH, Naeije R, Rubin LJ: Preoperative partitioning of pulmonary vascular resistance correlates with early outcome after thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Circulation 2004; 109: 18-22.